Allergan's Botox Patent Suit Should Proceed, Judge Says
A Delaware federal judge Thursday recommended denying a pair of biotech companies' bids to toss Allergan Inc.'s lawsuit accusing them of infringing several of its patents related to its Botox brand...To view the full article, register now.
Already a subscriber? Click here to view full article